A review of the psychomotor effects of paroxetine

International Clinical Psychopharmacology

Volumn 12, Issue 1, 1997, Pages 13-18

  Hawley, C J ^a   McPhee, S ^b   Quick, S J ^a   Smith, V R H ^a  

^a QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Behavioural; Cognitive; Paroxetine; Psychomotor; Review; Tests

Indexed keywords

PAROXETINE; PLACEBO;

ADVERSE DRUG REACTION; BEHAVIOR; CLINICAL TRIAL; HUMAN; META ANALYSIS; NEUROTOXICITY; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR DISORDER; REVIEW;

EID: 0030978674     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199701000-00002     Document Type: Review

References (24)

1. Boyer WF and Blumhardt CL (1992) The safety profile of paroxetine. Journal of Clinical Psychiatry, 53, (suppl), 61-66.
2. Cooper SM, Jackson D, Loudon JM et al. (1989) The psychomotor effects of paroxetine alone and in combination with haloperidol, amylobarbitone, oxazepam, or alcohol. Acta Psychiatrica Scandinavia, 80 (suppl 350), 53-55.
3. Deijen JB, Loriaux SM, Orlebeke JF et al. (1989) Effects of paroxetine and maprotiline on mood, perceptual-motor skills and eye movements in healthy volunteers. Journal of Psychopharmacology, 3, 149-155.
4. Dunbar GC, Cohn JB, Fahre LF et al. (1991) A comparison of paroxetine, imipramine and placebo in depressed outpatients. British Journal of Psychiatry, 159, 394-398
5. Dunner DL and Dunbar GC (1992) Optimal dose regime for paroxetine. Journal of Clinical Psychiatry, 53(2), (suppl), 21-26.
6. Feighner JP and Boyer WF (1991) The efficacy of selective serotonin re-uptake inhibitors in depression. In: Selective Serotonin Re-uptake Inhibitors (Eds JP Feighner and WF Boyer), pp. 89-108. John Wiley, Chichester.
7. Franks HM, Hensley BA, Hensley WJ, Starmer GA and Teo RKC (1976) The relationship between alcohol dosage and performance decrement. Journal of Studies on Alcohol, 37, 284-297.
8. Hatcher S, Sims R and Thompson D (1990) The effects of chronic lithium treatment on psychomotor performance related to driving. British Journal of Psychiatry, 157, 275-278.
9. Herberg KW (1993) Paroxetine and driving performance. In: Alcohol, Drugs and Traffic Safety - T92 (Eds HD Utzelmann, G Berghaus and G Kroj), pp. 552-555. Verlag TÜV Rheinland, Cologne.
10. Hindmarch I (1980) Psychomotor function and psychoactive drugs. British Journal of Clinical Psychopharmacology, 10, 189-209.
11. Hindmarch I and Gudgeon AC (1980) The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. British Journal of Clinical Psychopharmacology, 10, 145-150.
12. Hindmarch I and Harrison C (1988) The effects of paroxetine and other antidepressants in combination with alcohol on psychomotor activity related to car driving. Human Psychopharmacology, 3, 13-20.
13. Hindmarch I, Shillingford C, Vince M and Clarke A (1990). A double blind placebo-controlled investigation of the effects on psychomotor performance of paroxetine and amitriptyline with or without alcohol in adult subjects. Paper presented at CINP, Kyoto, September 1990.
14. Kerr JS, Fairweather DB, Mahendran R and Hindmarch I (1992) The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly. International Clinical Psychopharmacology, 7, 101-108.
15. Luria RE (1975) The validity of the visual analogue mood scale. Journal of Psychiatric Research, 12, 51-57.
16. MacPherson RD, Perl J and Starmer GA (1984) Self reported drug usage and crash incidence in breathalyzed drivers. Accident Analysis and Prevention, 16, 139-148.
17. McClelland GR and Raptopoulos P (1984) Psychomotor effects of paroxetine and amitriptyline, alone and in combination with ethanol. In: Proceedings of the British Psychological Society Dec 1984, 578P. British Psychological Society, Leicester.
18. O'Hanlon JF and Freeman H (1995). Categorising the behavioural toxicities of antidepressants. British Journal of Psychiatry, 166, 421-423.
19. Ray WA, Randy LF and Decker MD (1992) Psychoactive drugs and the risk of injurious motor vehicle crashes in the elderly. American Journal of Epidemiology, 136, 873-883.
20. Robbe HWJ and O'Hanlon JF (1995) Acute and subchronic effects of 20 and 40 mg paroxetine on actual driving, psychomotor performance and subjective assessments in healthy volunteers. European Neuropsychopharmacology, 5, 35-42.
21. Sherwood N and Hindmarch I (1993) A comparison of five commonly prescribed antidepressants with particular reference to their behavioural toxicity. Human Psychopharmacology, 8, 417-422.
22. Tasker TCG, McClelland GR, Raptopoulos P et al. (1988) Effects of the antidepressant paroxetine on psychomotor function, quantitative EEG and mood in healthy subjects. Psychopharmacology, 96 (suppl), 271.
23. Turner P (1968) Critical flicker frequency and centrally-acting drugs. British Journal of Ophthalmology, 52, 245-250.
24. Warrington SJ, Dana-Haeri J and Sinclair AJ (1989) Cardiovascular and psychomotor effects of repeated doses of paroxetine: a comparison with amitriptyline and placebo in healthy men.Acta Psychiatrica Scandinavia, 80 (suppl 350), 42-44.